Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Clarus CorpCLAR · Entity 6558 | Director | May 28, 2026 | June 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Clarus Corp
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $3.11 · Expires 2036-05-28 | Direct | 20,000 |
Reported balance
After 2026-05-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 20,000 · Balance 20,000 F1: The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2026 Filed Jun 1, 2026 20:16 UTC | Clarus Corp CLAR · Entity 6558 | GrantStock Option (right to purchase) · Derivative | 20,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001104659-26-068936 · tm2615758-4_4seq1.xml · derivative · entry 1 Werner Roger · CIK 0001331837 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2036-05-28 F1 · derivative.exercise_date: The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:44 UTC | Clarus Corp CLAR · Entity 6558 | GrantStock Option (right to purchase) · Derivative | 20,000 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001104659-25-055500 · tm2516657-4_4seq1.xml · derivative · entry 1 Werner Roger · CIK 0001331837 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-05-29 F1 · derivative.exercise_date: The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share ("Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026, respectively. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:21 UTC | Clarus Corp CLAR · Entity 6558 | GrantStock Option (right to purchase) · Derivative | 20,000 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001104659-24-067796 · tm2415863-6_4seq1.xml · derivative · entry 1 Werner Roger · CIK 0001331837 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-05-30 F1 · derivative.exercise_date: The options to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share ("Common Stock"), were granted under the Issuer's 2015 Stock Incentive Plan. The 20,000 options to purchase shares of the Issuer's Common Stock will vest and become exercisable in four equal consecutive tranches of 5,000 options on each of June 30, 2024, September 30, 2024, December 31, 2024, and March 31, 2025. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:19 UTC | Clarus Corp CLAR · Entity 6558 | GrantStock Option (right to purchase) · Derivative | 60,000 | $0.00 Strike: $6.75 | $0.00 |
DisclosureSEC source: 0001104659-24-033936 · tm248276-5_4seq1.xml · derivative · entry 1 Werner Roger · CIK 0001331837 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-03-11 F1 · derivative.exercise_date: The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share ("Common Stock"), were granted under the Issuer's 2015 Stock Incentive Plan. Options to purchase 60,000 shares of the Issuer's Common Stock will vest and become exercisable as follows: (i) 20,000 are immediately vested and exercisable on the date of grant; (ii) 20,000 will vest and become exercisable on March 11, 2025: and (iii) 20,000 will vest and become exercisable on March 11, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.